The HARMONY Alliance will welcome its official HARMONY and HARMONY PLUS Partners and Associated Members to meet up and discuss on research topics, achievements, and new activities within HARMONY and HARMONY PLUS
Dates / time: At Sunday 23 October we will welcome our participants for informal activities in the later afternoon and evening. The General Assembly program will start on Monday 24 October 2022 at 09:00 hrs and will end on Tuesday 25 October 2022 at approx.16:00 hrs.
Agenda: Find an overview of the General Assembly program activities here > (update per 21 October 2022)
Venue: Hotel Melia Palma Marina, Paseo Ingeniero Gabriel Roca, 29, Palma de Mallorca
Hotel recommendation: Book your stay on the Hotel Melia Palma Marina here to obtain a special discount.
Registration: We have closed the registration page per 19 October 2022. Would you still like to participate? email: communications@harmony-alliance.eu
* Note: All registrations are screened. Would you be interested to attend, however you are not an official HARMONY Alliance Partner or Associated Member? Please submit your motivation by email to qualify for a personal invitation, click here >.
General Assembly 2022
Focus of this year's edition:
Become involved
Are you interested in contributing to the HARMONY Alliance by providing data or other form of service? Scan our introduction folder here or just send us an email: communications@harmony-alliance.eu.
#BigDataforbloodcancer | Big Data accelerate better and faster treatment for Patients with Hematologic Malignancies
The HARMONY Alliance is a Public-Private Partnership for Big Data in Hematology including over 100 organizations such as European medical associations, hospitals, research institutes, patient organizations, pharmaceutical and IT companies.
The HARMONY Alliance is funded by the Innovative Medicines Initiative (IMI) (now called Innovative Health Initiative, IHI) of the European Commission and is currently running two projects: HARMONY (January 2017-June 2023) and HARMONY PLUS (October 2020-September 2023). In addition to the research projects that exploit the HARMONY Big Data Platform, the HARMONY Alliance is running Delphi surveys to develop core outcome sets for HMs, as well as Health Technology Assessment projects and multi-stakeholder activities.
HARMONY uses Big Data analytics to accelerate the development of more effective treatments for blood cancer patients. Data are stored in the HARMONY Big Data Platform, which has already identified over 119,000 anonymized patient records, making it one of the largest databases of its kind. Leading research teams are currently using this wealth of information to answer critical questions about hematologic malignancies that cannot be addressed with other methods.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
